SOTERA HEALTH COMPANY Increase (Decrease) in Accrued Liabilities
SOTERA HEALTH COMPANY (SHC) reported Increase (Decrease) in Accrued Liabilities of -$11.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- SOTERA HEALTH COMPANY increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$205.00K.
- SOTERA HEALTH COMPANY increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$10.86M.
- SOTERA HEALTH COMPANY increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$11.34M, a 211.90% decline year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $27.79M, a 78.54% increase year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in accrued liabilities for fiscal 2025 was $1.94M, a 72.72% decline from fiscal 2024.
- SOTERA HEALTH COMPANY increase (decrease) in accrued liabilities for fiscal 2024 was $7.11M, a 103.26% increase from fiscal 2023.
- SOTERA HEALTH COMPANY increase (decrease) in accrued liabilities for fiscal 2023 was $3.50M, a 83.01% decline from fiscal 2022.
- SOTERA HEALTH COMPANY increase (decrease) in accrued liabilities for fiscal 2022 was $20.59M, a 1190.41% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$11.07M 10-Q · filed 2026-08-06 | -$22.41M derived: sum of 3 quarters · filed 2026-08-06 | $5.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$10.86M 10-Q · filed 2026-05-05 | -$22.20M derived: sum of 2 quarters · filed 2026-05-05 | $5.59M derived: sum of 3 quarters · filed 2026-05-05 | $1.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$11.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $16.45M derived: sum of 2 quarters · filed 2026-02-24 | $12.11M derived: sum of 3 quarters · filed 2026-08-06 | $1.94M 10-K · filed 2026-02-24 |
| 2025-09-30 | $27.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $23.45M derived: sum of 2 quarters · filed 2026-08-06 | $13.28M 10-Q · filed 2025-11-04 | $23.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$4.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$14.51M 10-Q · filed 2026-08-06 | -$4.38M derived: sum of 3 quarters · filed 2026-08-06 | $11.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$10.17M 10-Q · filed 2026-05-05 | -$37.00K derived: sum of 2 quarters · filed 2026-05-05 | $15.53M derived: sum of 3 quarters · filed 2026-05-05 | $27.95M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $10.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $25.70M derived: sum of 2 quarters · filed 2026-02-24 | $38.12M derived: sum of 3 quarters · filed 2026-02-24 | $7.11M 10-K · filed 2026-02-24 |
| 2024-09-30 | $15.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $27.99M derived: sum of 2 quarters · filed 2025-11-04 | -$3.02M 10-Q · filed 2025-11-04 | $11.87M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $12.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$18.59M 10-Q · filed 2025-08-08 | -$3.70M derived: sum of 3 quarters · filed 2026-02-24 | -$37.36M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$31.01M 10-Q · filed 2025-05-01 | -$16.12M derived: sum of 2 quarters · filed 2026-02-24 | -$49.78M derived: sum of 3 quarters · filed 2026-02-24 | -$36.33M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $14.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$18.77M derived: sum of 2 quarters · filed 2026-02-24 | -$5.33M derived: sum of 3 quarters · filed 2026-02-24 | $3.50M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$33.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$20.21M derived: sum of 2 quarters · filed 2024-11-05 | -$11.39M 10-Q · filed 2024-11-05 | $11.08M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $13.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $22.27M 10-Q · filed 2024-08-05 | $44.74M derived: sum of 3 quarters · filed 2025-02-27 | $54.74M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $8.83M 10-Q · filed 2024-05-02 | $31.30M derived: sum of 2 quarters · filed 2025-02-27 | $41.29M derived: sum of 3 quarters · filed 2025-02-27 | $26.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $22.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $32.46M derived: sum of 2 quarters · filed 2025-02-27 | $18.12M derived: sum of 3 quarters · filed 2025-02-27 | $20.59M 10-K · filed 2025-02-27 |
| 2022-09-30 | $9.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$4.35M derived: sum of 2 quarters · filed 2023-11-01 | -$1.87M 10-Q · filed 2023-11-01 | $7.71M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$14.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$11.87M 10-Q · filed 2023-08-03 | -$2.29M derived: sum of 3 quarters · filed 2024-02-27 | -$5.90M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $2.48M 10-Q · filed 2023-05-03 | $12.06M derived: sum of 2 quarters · filed 2024-02-27 | $8.45M derived: sum of 3 quarters · filed 2024-02-27 | $9.62M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $9.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $5.97M derived: sum of 2 quarters · filed 2024-02-27 | $7.14M derived: sum of 3 quarters · filed 2024-02-27 | $1.60M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$3.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$2.44M derived: sum of 2 quarters · filed 2022-11-02 | -$7.99M 10-Q · filed 2022-11-02 | -$7.77M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$4.38M 10-Q · filed 2022-08-04 | -$4.16M derived: sum of 3 quarters · filed 2023-02-28 | $6.12M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$5.54M 10-Q · filed 2022-05-05 | -$5.32M derived: sum of 2 quarters · filed 2023-02-28 | $4.95M derived: sum of 3 quarters · filed 2023-02-28 | $6.04M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $10.49M derived: sum of 2 quarters · filed 2023-02-28 | $11.58M derived: sum of 3 quarters · filed 2023-02-28 | $3.25M 10-K · filed 2023-02-28 |
| 2020-09-30 | $10.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $11.36M derived: sum of 2 quarters · filed 2021-11-10 | $3.03M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$7.25M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$8.33M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$18.41M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |